Related Experiment Video
Updated: Mar 30, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Probiotic supplementation influences faecal short chain fatty acids in infants at high risk for eczema
H K Kim1,2, N B M M Rutten3, I Besseling-van der Vaart2
11 Natural Product Laboratory, Institute of Biology, Leiden University, P.O. Box 9502, 2300 RA Leiden, the Netherlands.
Insights
Probiotic supplementation in infants may prevent eczema by altering gut bacteria metabolites. Early gut metabolic differences were observed in children who later developed eczema, suggesting a role in immune system development.
Area of Science:
- Microbiology
- Immunology
- Metabolomics
Background:
- Gut microbiota composition influences allergy development.
- Probiotics are investigated for preventing childhood eczema due to their immunomodulating effects.
- Previous research indicated reduced eczema incidence with specific probiotic strains at three months of age.
Purpose of the Study:
- To investigate gut metabolic alterations in infants using (1)H-nuclear magnetic resonance (NMR) spectroscopy.
- To identify specific fecal metabolites associated with eczema development in early childhood.
- To explore the impact of probiotic supplementation on infant gut metabolomics.
Main Methods:
- Analysis of fecal samples from 3-month-old infants using (1)H-NMR.
- Comparison of metabolite profiles between infants who developed eczema and those who did not.
- Assessment of metabolite changes in infants receiving probiotic supplementation versus placebo.
Main Results:
- Infants later developing eczema showed lower levels of short-chain fatty acids (SCFAs), succinate, phenylalanine, and alanine, and higher levels of glucose, galactose, lactate, and lactose at 3 months.
- Probiotic supplementation was associated with increased lactate and SCFAs, and decreased lactose and succinate compared to placebo.
- Metabolic alterations were detectable at 3 months, preceding the clinical manifestation of eczema, which often appeared by 1 year of age.
Conclusions:
- Gut bacterial metabolites play a role in immune system development and may influence the onset of allergic diseases like eczema.
- Early-life metabolic profiles in the gut could serve as potential biomarkers for eczema risk.
- Probiotics may exert a preventive effect on eczema development through modulation of gut metabolites, such as increasing SCFAs and lactate.
Abstract:
The composition of the gut microbiota plays a role in the development of allergies. Based on the immunomodulating capacities of bacteria, various studies have investigated the potential role for probiotics in the prevention of childhood eczema. In a previous study we have shown that significantly less children developed eczema after probiotic supplementation (Bifidobacterium bifidum W23, Bifidobacterium animalis subsp. lactis W52 and Lactococcus lactis W58, Ecologic(®)Panda) at three months of age as compared to controls. Here, metabolites in faecal samples of these 3-month old children were measured by (1)H-nuclear magnetic resonance to investigate possible gut metabolic alterations. Lower amounts of short-chain fatty acids (SCFAs), succinate, phenylalanine and alanine were found in faecal samples of children later developing eczema, whereas the amounts of glucose, galactose, lactate and lactose were higher compared to the children not developing eczema. Although these differences were already present at the age of 3 months, eczema did not develop in the majority of children before the age of 1 year. Supplementation of multispecies probiotics seems to induce higher levels of lactate and SCFAs, and lower levels of lactose and succinate when compared with the placebo group. This might explain the temporary preventive effect of probiotics on the development of eczema. These results highlight the role bacterial metabolites may play in development of the immune system, even before clinical manifestations of allergic disease arise.
More Related Videos
07:15An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
09:36Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Related Concept Videos
Development of Human Microbiota
Probiotics
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Development of the Oral Microbiota
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Introduction to the Human Microbiota